Generally, ATTR cardiac amyloidosis is a slowly progressive disease with a final common pathophysiologic pathway of diastolic and systolic cardiac dysfunction and the definitive therapy would be an orthotopic liver transplantation to replace mutant TTR to arrest amyloid formation [19, 20]. The gene discussed is TTR; the disease is cardiac amyloidosis.